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Preventing preterm births: analysis of trends and potential 
reductions with interventions in 39 countries with very high 
human development index
Hannah H Chang, Jim Larson, Hannah Blencowe, Catherine Y Spong, Christopher P Howson, Sarah Cairns-Smith, Eve M Lackritz, Shoo K Lee, 
Elizabeth Mason, Andrew C Serazin, Salimah Walani, Joe Leigh Simpson, Joy E Lawn, on behalf of the Born Too Soon preterm prevention analysis group
Summary
Background Every year, 1·1 million babies die from prematurity, and many survivors are disabled. Worldwide, 
15 million babies are born preterm (<37 weeks’ gestation), with two decades of increasing rates in almost all countries 
with reliable data. The understanding of drivers and potential beneﬁ t of preventive interventions for preterm births is 
poor. We examined trends and estimate the potential reduction in preterm births for countries with very high human 
development index (VHHDI) if present evidence-based interventions were widely implemented. This analysis is to 
inform a rate reduction target for Born Too Soon.
Methods Countries were assessed for inclusion based on availability and quality of preterm prevalence data (2000–10), 
and trend analyses with projections undertaken. We analysed drivers of rate increases in the USA, 1989–2004. For 
39 countries with VHHDI with more than 10 000 births, we did country-by-country analyses based on target 
population, incremental coverage increase, and intervention eﬃ  cacy. We estimated cost savings on the basis of 
reported costs for preterm care in the USA adjusted using World Bank purchasing power parity.
Findings From 2010, even if all countries with VHHDI achieved annual preterm birth rate reductions of the best 
performers for 1990–2010 (Estonia and Croatia), 2000–10 (Sweden and Netherlands), or 2005–10 (Lithuania, Estonia), 
rates would experience a relative reduction of less than 5% by 2015 on average across the 39 countries. Our analysis 
of preterm birth rise 1989–2004 in USA suggests half the change is unexplained, but important drivers include non-
medically indicated labour induction and caesarean delivery and assisted reproductive technologies. For all 
39 countries with VHHDI, ﬁ ve interventions modelling at high coverage predicted a 5% relative reduction of preterm 
birth rate from 9·59% to 9·07% of livebirths: smoking cessation (0·01 rate reduction), decreasing multiple embryo 
transfers during assisted reproductive technologies (0·06), cervical cerclage (0·15), progesterone supplementation 
(0·01), and reduction of non-medically indicated labour induction or caesarean delivery (0·29). These ﬁ ndings 
translate to roughly 58 000 preterm births averted and total annual economic cost savings of about US$3 billion.
Interpretation We recommend a conservative target of a relative reduction in preterm birth rates of 5% by 2015. Our 
ﬁ ndings highlight the urgent need for research into underlying mechanisms of preterm births, and development of 
innovative interventions. Furthermore, the highest preterm birth rates occur in low-income settings where the causes 
of prematurity might diﬀ er and have simpler solutions such as birth spacing and treatment of infections in pregnancy 
than in high-income countries. Urgent focus on these settings is also crucial to reduce preterm births worldwide.
Funding March of Dimes, USA, Eunice Kennedy Shriver National Institute of Child Health and Human Development, 
and National Institutes of Health, USA.
Introduction
Every year, about 1·1 million neonates die from com-
plications of preterm birth as estimated in 2010.1 Preterm 
birth is now worldwide the second most common cause-
of-death in children younger than 5 years after pneu monia, 
and is decreasing at a much slower rate than pneumonia, 
even increasing in several countries. Add itionally, preterm 
birth is the leading risk factor for 393 000 deaths due to 
neonatal infections and contributes to long-term growth 
impairment and substantial long-term morbidity such as 
cognitive, visual, and learning impairments.2,3
The ﬁ rst-ever national estimates of preterm birth 
(deﬁ ned as <37 completed weeks of gestation) were 
recently published in The Lancet,4 undertaken with the 
WHO, and included a country clearance process in 
which all UN member states countries were invited to 
review their estimates and provide feedback. These esti-
mates showed a total of 15 million babies born preterm 
in 2010, 5% of which were under 28 weeks’ gesta tion.4 
Time trends for 65 countries from the Millennium 
Develop ment Goals (MDG) Developed region, Latin 
America, and the Caribbean region, where more reliable 
data were available, showed that almost all these 
countries have had increased rates of preterm birth over 
the past two decades.
Born Too Soon: The Global Action Report on Preterm 
Birth5 was based on these estimates and outlined evi-
dence for interventions along the continuum of care 
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from preconception, through pregnancy, birth, and for 
newborn care.5 Reduction in preterm mortality in high-
income countries has been largely due to improved care 
and policy changes, and this care has yet to be scaled up 
in most low-income and middle-income countries.5 
Born Too Soon set a goal of 50% reduction of preterm 
speciﬁ c mortality by 2025, which was based on historical 
reductions in the USA and UK, rates of reduction of 
preterm-speciﬁ c deaths in well performing low-income 
and middle-income countries, and an analysis of lives 
saved with very feasible interventions such as kangaroo 
mother care and antenatal steroids. The report was a 
joint eﬀ ort involving 50 organisations, it has a Foreword 
by the UN Secretary-General, and contains new com-
mitments by 31 organisations linked to the accountability 
framework of the Every Woman Every Child movement.5 
The survival gap for preterm babies is mainly an action 
gap for intervention implementation low-income and 
middle-income countries. However, the the worldwide 
epidemic of preterm birth aﬀ ects low-income, middle-
income, and high-income countries alike, and the gap 
for preterm prevention is mainly a knowledge gap. Our 
understanding of the underlying drivers for preterm 
birth or the potential eﬀ ect of preventive interventions 
remains poor, although recent advances in classiﬁ cation 
of the preterm birth syndrome provide helpful advances. 
Born Too Soon therefore recommended that “a technical 
expert group will be created to consider a goal for 
reduction of preterm birth rate by 2025 for announce-
ment on World Prematurity Day 2012.”5,6
Thus, our aim was to do a multicountry analysis of the 
trends in preterm birth rates for 2000–10 in countries 
with more robust data, and to estimate the potential 
reduction in preterm birth with full imple mentation of 
currently proven interventions. A sec ondary objective 
was to consider the setting of a preterm birth reduction 
target for these countries.
Methods
Assessment of national data and time trends for 
preterm birth rates
Recent national estimates4 of preterm births were based 
on 738 reported data inputs from 99 countries, from 
1990 to 2010. This analysis identiﬁ ed a paucity of con-
sistent reliable data for countries in regions without 
robust registration systems. Hence, a statistical model 
was used to estimate preterm birth rates in 2010 for 
184 countries with more than 10 000 livebirths, but it was 
unable to estimate time trends in low-income and most 
middle-income countries. Most input data (547 of 738) 
were from the 65 countries in the Developed, Latin 
America, and the Caribbean MDG regions. Hence the 
1990–2010 time trend analysis was focused on these 
countries with use of country-level Loess regression to 
smooth reported data for the 12 countries with adequate 
data during the 21-year period and statistical modelling 
with own and regional data for the other 53 countries.4 
Loess regression is a locally weighted regression method, 
it was used to ﬁ t a smooth curve to the country-speciﬁ c 
preterm data using a weighted least squares method to 
184 countries with 
estimated 2010 preterm 
birth rates
Exclusion of countries without 
reliable time trends or 
<10 000 livebirths per year
65 countries with 
estimated preterm birth 
rates for 1990–2010 
Exclusion of countries with modelled 
estimates for preterm birth rates
16 countries with 
high-quality reported 
preterm birth rates 
for 2000–10
12 countries with 
high-quality preterm 
birth rates from Loess 
regression for 1990–2010
28 countries with 
high-quality preterm 
birth rates for 2000–10
Options of 
country 
groupings for 
“high-income” 
countries
UN Statistics Division 
“developed region”
(n=61)
World Bank 
“high-income 
economies”
(n=70) 
UN Development 
Programme “very high human 
development index countries”
(n=47)
Millennium 
Development Goals 
“developed region”
(N=55)
Exclusion of countries with fewer than 10 000 livebirths in 2010
Identification of the proportion of these countries with high-quality preterm birth data for 2000–10
Number of 
countries 
with  
>10 000 
livebirths 
per year
Percent of 
countries in the 
above grouping
with high-quality 
preterm birth 
data for 2000–10 
Step 1
A B
Step 2
CombinationStep 3
All with >10 000 livebirths per year 
n=40 n=40 n=39 n=42
n=24 n=22 n=26 n=24
60% 55% 67% 57%
Step 1
Step 2
Figure 1: Country selection process for preterm birth rate trends analyses
n=number of countries. (A) Inclusion criteria for countries with reliable preterm birth trend data. (B) Examination of “high-income” country groupings with best ﬁ t for countries with high-quality 
preterm birth data. Data of preterm prevalence from Blencowe H and colleagues.4 For country groupings see appendix (pp 1–2).
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minimise year on year ﬂ uctuations. This method makes 
use of the data available from the speciﬁ c country to 
provide estimates for every year, giving more weight to 
the datapoints nearest to the year estimating for.7
Inclusion criteria and regional grouping
We assessed the data from these 65 countries with a focus 
on the 2000–10 period. High-quality data were available 
for 28 countries for that period (ﬁ gure 1A). We excluded 
countries with fewer than 10 000 livebirths in 2010 from 
all deﬁ nitions of high-income countries in accordance 
with the method ology used in the previous time trends 
analyses by Blencowe and colleagues4 (appendix pp 1–2).
To identify the most appropriate regional grouping with 
a high proportion of the countries having good quality 
data, we examined various deﬁ nitions of high-income or 
developed countries to identify which grouping contained 
the highest share of these countries with high-quality data 
availability. We considered the following four options: 
World Bank “high-income economies”, UN Development 
Programme “Very High Human Development Index” 
(VHHDI), UN Statistics Division “developed region”, and 
the MDG “developed region”. The 26 countries with high-
quality data constituted 67% of the 39 UN Develop-
ment Programme VHHDI countries with more than 
10 000 livebirths per year, the highest of the four options 
examined (ﬁ gure 1B). Of these 47 countries with VHHDI, 
39 had more than 10 000 livebirths per year and were 
included in our analysis (appendix p 2). 26 of these 
countries had high-quality reported or Loess data (6% of 
global preterm births from 2010) and for the remaining 
13 countries, we used their own data with modelled 
adjustment from Blencowe and colleagues4 (2% of global 
births in 2010; ﬁ gure 2, appendix pp 3–4).
To estimate the potential eﬀ ect of preventive inter-
ventions for these 39 countries with VHHDI, we used 
the 2010 preterm birth rates as the baseline, pre-inter-
vention preterm birth rate (appendix p 5). We analysed 
the average annual rate of change (AARC) of preterm 
birth rate for diﬀ erent time periods, including only 
countries with VHHDI with high-quality data for 
pre term birth rates spanning at least 5 of the 6 years for 
every time period (eg, 2000–05, 2005–10; appendix p 6). 
This exclusion was to minimise the eﬀ ect of year-to-year 
ﬂ uctuations on the AARC and helped to more accurately 
represent the overall trend. 23 of the 39 countries with 
VHHDI had enough data for estimating the AARC for 
both 2000–05 and 2005–10 time periods.
We did a projection of potential reduction in preterm 
births to estimate the reduction in countries with VHHDI 
if all countries achieved the same as those with the greatest 
reduction in preterm birth rates for three diﬀ erent 
periods: 1990–2010, 2000–10, and 2005–10. The average of 
the annual rate of change for the two countries with the 
highest rate of reduction during each period was then 
used to project preterm birth rates for years 2010 to 
Countries with modelled preterm 
birth rates for 1990–2010
Countries with high-quality preterm birth rates 
from Loess regression for 2000–10
Countries with high-quality reported preterm 
birth rates for 2000–10 
Constitutes 14% of 2010 
worldwide preterm births
Constitutes 6% of 2010 
worldwide preterm births
Figure 2: Preterm birth trend data availability by country, 1990–2010
Data of preterm prevalence data availability from Blencowe H and colleagues.4 Some countries with high-quality data only had data for subnational populations 
(eg, UK and Belgium).
See Online for appendix
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2015 for all countries with VHHDI, weighted by 
2010 preterm births for every country (appendix p 7).
Analysis of drivers for rise in preterm birth in USA
We analysed the rise in preterm births in the USA. We 
selected the USA because of its high preterm birth rate 
(double most European countries), its rising rates then 
recent reductions suggesting a changing pattern, and its 
data availability for rates and drivers, but this analysis was 
not applied to other countries. We identiﬁ ed po tential 
drivers that might have contributed to the rising rate of 
preterm births in the USA between 1989 and 2004 on the 
basis of scientiﬁ c literature and discussions with the Born 
Too Soon preterm prevention analysis group.8 To estimate 
the contributions from every driver, we took the following 
approach: (1) identify the distri bution of mothers aﬀ ected 
(eg, maternal age), (2) identify the risk of preterm birth 
for every category (eg, by maternal age), and (3) calculate 
the total contribution to the diﬀ erence in preterm birth 
rate between 1989 and 2004 for every driver. Importantly, 
we avoided overlap of contributions from diﬀ erent drivers 
in the analysis by using preterm birth odds ratios (ORs) 
from logistical regression modelling that simultaneously 
controlled for all except the variable of interest using 
individualised data (eg, maternal age is associated with 
increased use of assisted reproductive technologies).8,9 We 
calculated the contribution to the diﬀ erence in preterm 
birth rate between 1989 and 2004 for every age group by 
multiplying the percentage of mothers in every age group 
with the corresponding OR and subtracting the result for 
1989 from 2004. Details on speciﬁ c data sources and 
methodology are presented in the appendix (pp 8–14).8,10–14
Estimation of the eﬀ ect of interventions to reduce 
preterm birth
We used the Global Alliance to Prevent Prematurity and 
Stillbirth (GAPPS) Review Group report15 to identify a 
list of preventive interventions for consideration. The 
GAPPS team systematically assessed about 2000 inter-
vention studies published up until Dec 31, 2008, and 
applied an adaptation of the Grades of Recommendation 
Assessment, Development, and Evaluation (GRADE) 
criteria.15 Three preventive interventions had a high level 
of evidence (smoking cessation, progesterone, and zinc 
supple men tation), but only two (smoking cessation and 
proges terone) were strongly recommended for imple-
mentation for preterm birth prevention and were 
included in our analysis (table).
For the 18 interventions in the GAPPS review15 with 
“very low,” “low”, and “moderate” evidence of eﬃ  cacy, or 
“high” level of evidence for no eﬀ ect, we searched for new 
evidence published since 2008 that might change these 
assessments (appendix p 15). We focused on high-quality 
reviews such as Cochrane, and identiﬁ ed new reports for 
seven interventions (cervical cerclage, micro nutrient 
supple mentation, protein energy supplemen tation, iron 
and folate supplementation, magnesium sulphate supple-
mentation, screening and treatment of asympto matic 
bacteriuria, and multivitamins for HIV-positive women). 
Of these, only cervical cerclage had a notable change in 
evidence for eﬃ  cacy on prevention of preterm births.16,17 
New evidence showed that “in women with previous 
spontaneous preterm birth, singleton gestation, and 
cervical length less than 25 mm, cervical cerclage sig-
niﬁ cantly prevents pre term birth and com posite perinatal 
mortality and morbidity.”15,16 Thus, we included cervical 
cerclage in our analysis. The GAPPS review15 focused on 
interventions relevant to the low-income and middle-
income countries so we also in cluded two interventions 
of relevance to high-income countries, notably decrease 
of non-medically indicated caesarean delivery and labour 
induction and limiting multiple-embryo transfer in 
assisted reproductive technologies.
For the analysis on decreasing multiple births from 
assisted reproductive technologies, we used the Euro-
pean average for countries without available reported 
Evidence of eﬃ  cacy 
for preterm birth 
by GRADE criteria
Recommendation 
for implementation 
for preterm birth
Rationale for inclusion or exclusion in analysis
Smoking cessation High (eﬀ ect) Strong Included: GRADE recommendation according to GAPPS
Progesterone High (eﬀ ect) Strong Included : GRADE recommendation according to GAPPS
Cerclage High (no eﬀ ect) Strong (against) Included: newer evidence16 shows eﬃ  cacy in women with previous 
preterm birth and short cervix. Potential for implementation expected to 
be high among HIC, unlike that for LIC and MIC, which was focus of GAPPS
Decrease in non-medically indicated 
caesarean delivery and induction
NA NA Included: relevant in HIC (not included in GAPPS because of the focus on 
LIC and MIC)
Limit multiple embryo transfer in 
assisted reproductive technology
NA NA Included: relevant in HIC (not included in GAPPS because of the focus on 
LIC and MIC)
Zinc supplementation Non-signiﬁ cant Weak Excluded: weak GRADE recommendation according to GAPPS
GAPPS=Global Alliance for Prevention of Prematurity and Stillbirth report.15 New evidence supporting eﬃ  cacy of cerclage from Berghella and colleagues Obstetrics and 
Gynecology 2011.16 GRADE=grading of recommendations assessment, development, and evaluation. HIC=high-income countries. MIC=middle-income countries. 
LIC=low-income countries. NA=not applicable. Appendix (pp 16–17) for eﬀ ect estimate applied for each intervention and appendix (p 15) for other interventions that were 
considered but excluded from analysis.
Table: Interventions meeting selection criteria for analysis of prevention of preterm birth
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data for total livebirths with assisted reproductive 
technologies, present rate of multiple births from these 
technologies, and preterm birth rate associated with each 
plurality in these technologies.18 We assumed the target 
plurality distribution for births with assisted reproductive 
technologies to be 
singleton : twins : triplet = 89·5% : 10·0% : 0·5% 
on the basis of expert opinion about plurality distribution 
if most live births these technologies resulted from single 
embryo transfer. 
We did country-by-country analyses of the potential 
reduction in preterm birth rates for the ﬁ ve included 
interventions. The general approach was: (1) identify and 
size of the target population for the intervention, 
(2) estimate the incremental coverage for the interven-
tion to reach full coverage of the target population, 
(3) estimate the expected eﬃ  cacy for the intervention, 
and ﬁ nally (4) obtain the estimated impact in reduction 
of preterm birth rate and preterm births averted 
(population attributable risk) and combine this for the 
39 countries with VHHDI weighted by the country’s 
number of preterm births for 2010.
15
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Figure 3: Preterm birth rates and time trends for VHHDI countries
VHHDI=very high human development index. AARC=average annual rate of change. (A) Preterm birth rates per 100 livebirths in 2010 (baseline) for 39 countries with 
VHHDI. (B) AARC in preterm rates 2000–10 for 26 countries with VHHDI with high-quality data and more than 10 000 births. (C) AARC groupings 2000–05, 2005–10, 
for 23 countries with VHHDI with preterm birth data spanning at least 5 years within each 6-year period.
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Eﬃ  cacy for every intervention was based on scientiﬁ c 
literature applying the following hierarchy: Cochrane 
Review, meta-analysis, randomised controlled trials, and 
other studies. The data used and speciﬁ c method ology 
for every analysis can be found in the appendix 
(pp 16–31).8,10,17–30 For assisted reproductive technologies, 
eﬃ  cacy of the intervention was estimated as the 
diﬀ erence between the existing rate of preterm births 
among livebirths associated with assisted repro ductive 
technologies of each plurality (ie, twins and triplets) and 
that of an ideal plurality distribution (appendix p 17). 
This so-called ideal plurality distribution among live-
births associated with assisted reproductive tech nologies 
was set as a rounded average of performance in countries 
with VHHDI already with very low multiple births from 
assisted reproductive technologies (ie, Sweden) and the 
current European average.18 For cae sarean delivery and 
labour induction, we assumed a goal of 80% combined 
elimination for the analysis. This is an optimistic but not 
unrealistic goal, as experiences in the USA have shown 
that more than 80% reduction (25% to <5%) in elec-
tive delivery between 36 (0/7)–38 (6/7) weeks without a 
documented medical indication is possible within 
2 years.31 Coverage data were sourced from national 
health databases and statistical oﬃ  ces.
Estimation of potential cost savings
We calculated the economic cost savings associated with 
reduction in preterm birth rate using the projected 
number of preterm births averted for every country 
and the incremental cost associated with every preterm 
birth. It has been estimated that the total economic 
cost, including the costs of medical care services, early 
intervention services, special education services, and 
lost household and labour market productivity was 
US$51 600 per preterm birth in the USA in 2005.32 Other 
more sensitive cost analysis using gestation-speciﬁ c 
additional costs would be preferred but were not possible 
because of not enough data by country and on the same 
gestation speciﬁ c banding.33 Using purchasing power 
parity conversion factor from the World Bank, we 
obtained the estimated incremental cost of preterm birth 
in the local currency of every VHHDI country (appendix 
pp 32–35). Then, we converted the cost for every country 
into US$ using currency exchange rates from the World 
Bank and Organization for Economic Co-operation and 
Develop ment (OECD; appendix pp 32–33).
Role of the funding source
The sponsoring agencies ﬁ nancial management had no 
role in study design, data collection, data analysis, data 
interpretation, or writing of the report. HHC, JL, HB, 
and JEL had full access to all the data in the study and 
had ﬁ nal responsibility for the decision to submit for 
publication.
Results
The estimated 2010 preterm birth rates varied between 
countries with VHHDI, from 5·3 per 100 livebirths in 
Latvia to 14·7 per 100 livebirths in Cyprus (ﬁ gure 3). 
172 datapoints were available for 26 of the 39 countries 
with VHHDI from 2000 to 2010 (ﬁ gure 1, appendix p 6)4 
indicating that preterm birth rates have increased for 
most of the 26 countries between 2000 and 2010 
(ﬁ gure 3). However, on average, the countries with 
VHHDI have seen a levelling of preterm birth rates more 
recently from 2005 to 2010. This new ﬁ nding is shown by 
an increasing proportion of countries (>60% or 14 of 
23 countries) with a stable (0·5% to –0·5%) or decreasing 
(<–0·5%) pre term birth rate when comparing that for 
2000–05 and 2005–10 (ﬁ gure 3).
National trends in preterm birth rates are a poor 
predictor of future trends in many of the 39 countries 
(appendix p 36). We estimated the 2015 preterm birth 
rate for every country assuming each followed its historic 
 AARC for 2000–10 and 2005–10, or alternatively, as being 
stable since 2010 (appendix pp 37–38). No consistent 
pattern was identiﬁ able. In some countries the stable 
assumption will yield the highest projection, whereas in 
others the lowest. These two ﬁ ndings (levelling of trends 
2005–10 and inconsistent projections based on historic 
data) suggest that modelling future preterm birth rates 
with a ﬂ at baseline as the counterfactual is an appropriate 
and conservative approach.
To estimate potential reduction of preterm birth rates if 
all countries achieved the same progress as that of the best 
performing countries, we projected the average pre-
term birth rate for all countries with VHHDI for 
2010–15 assuming they all reduced their preterm birth 
rate as fast as the average of the two best performers for 
various time periods (1990–2010 for Estonia and Croatia; 
2000–10 for Sweden, the Netherlands; and 2005–10 for 
Lithuania and Estonia; appendix p 7). From the 2010 base-
line to 2015, whichever historical time period was used, 
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Figure 4: Preterm birth rates for 2010 in VHHDI countries projected to 2015 considering various scenarios 
such as AARC for top performing countries in diﬀ erent time periods, or high coverage of the ﬁ ve 
preventive interventions
VHHDI=very high human development index. AARC=average annual rate of change. See appendix (pp 16–31) 
for details.
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the projection resulted in roughly 5% relative reduction in 
preterm birth rate by 2015, similar to the relative reduction 
of about 5% in our intervention analysis (ﬁ gure 4).
The preterm birth rate in the USA increased from 
10·6% to 12·5% between 1989 and 2004.11 We estimated 
the contribution to the increase in preterm birth 
rate during this time from seven diﬀ erent drivers 
(ﬁ gure 5; appendix pp 8–14).8,10–14 For example, mothers in 
2004 were older than in 1989, with a simultaneous 
increase in mothers older than 40 years and decrease of 
those younger than 19 years. The ORs for preterm birth 
(adjusted for all other variables) were highest for the 
oldest and youngest mothers, at 1·7 times (oldest) and 
1·6 (youngest) times that of control (age 20–24 years).8
Only about 50% (0·91%/1·90%) of the change in 
preterm birth rate between 1989 and 2004 can be ex-
plained by the seven drivers, with non-indicated cesarean 
delivery and labour induction together accounting for 
about 20% (0·4/1·90%) of the change (ﬁ gure 5). This 
analysis shows the contribution of these drivers to the 
change, rather than contribution to the absolute preterm 
birth rate, which would require a more comprehensive 
understanding of the pathogenesis of preterm birth than 
is presently available.
We estimated the potential eﬀ ect of existing interven-
tions in lowering preterm birth rates in the countries 
with VHHDI. We focused on ﬁ ve interventions meeting 
inclusion criteria: smoking cessation, progesterone, 
cervical cerclage, decreasing non-medically indicated 
labour or caesarean delivery induction, and decreasing 
multiple births from assisted reproductive technologies 
(table).8,10,17–29 Combining the size of the target popu lation, 
incremental increase in coverage, and eﬃ  cacy of 
interventions, we obtained estimates for potential re-
duction in preterm birth rate for each intervention 
(appendix pp 16–17).
In 39 countries with VHHDI, by applying these ﬁ ve 
selected interventions preterm birth rates can have a 
relative reduction of an estimated 5%, corresponding to 
change in absolute preterm birth rate from 9·6% to 9·1% 
(ﬁ gure 6, appendix pp 39–40). Reduction of non-
medically indicated caesarean delivery and induction of 
labour has the largest eﬀ ect, accounting for roughly half 
of the impact. However, signiﬁ cant variability exists 
across countries in the absolute impact (about 1% to 
roughly 8% relative reduction), but also the relative 
contribution of individual interventions that is variable 
across countries (appendix pp 41–60). For example, 
whereas reduction of non-indicated caesarean delivery 
and labour induction has the highest impact in the 
USA, it would make a negligible diﬀ erence in Sweden 
(ﬁ gure 6B, C). By contrast, cervical cerclage for women 
with previous preterm birth and short cervix is estimated 
to have most impact in Sweden (ﬁ gure 6C).
If 5% relative reduction is achieved by the included 
countries, about 58 000 preterm births can be averted 
annually (appendix pp 61–62), amounting to roughly 
US$3·0 billion in total economic cost savings (appendix 
p 32–35). This projected cost savings is signiﬁ cant but 
still leaves a major cost and burden, highlighting the 
need for novel preventive interventions against preterm 
birth with greater impact.
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Discussion
Although preterm birth is the leading cause of death for 
children younger than 5 years in high-income countries, 
second leading cause worldwide, and a major contributor 
to the Global Burden of Disease, this is the ﬁ rst multi-
country analysis of trends in preterm birth rates and the 
potential for prevention through existing interventions 
(panel). Shockingly, very little reduction is currently 
possible. Even with assumed optimum coverage of these 
interventions in countries with VHHDI, the potential 
reduction in preterm birth rate is tiny, with about 
58 000 preterm births averted across 39 countries, but the 
associated US$3 billion total economic cost savings is 
impressive given the complexity of care provided in USA 
for very preterm babies.
These analyses were limited to the countries with 
VHHDI because of the scarcity of time trend data in 
low-income countries, even though rates of preterm 
births are generally higher in low-income countries. 
Additionally, several of the interventions we modelled are 
not relevant for low-income settings—ie, in rural west 
Africa, the caesarean delivery rate is almost zero, so 
excess caesarean deliveries are not the issue. Further-
more, some interventions such as cervical cerclage would 
not be feasible in such settings.
On the basis of these analyses, we propose a target of 5% 
relative reduction by 2015 on average across the countries 
with VHHDI. There were two motivations for proposing a 
near-future target of 2015 as compared with a later date. 
First, this date is feasible, because in the top-performing 
countries with VHHDI, AARC in preterm birth translates 
to about 5% relative reduction in 5 years (ﬁ gure 4). Second, 
our hope is that this target will motivate immediate action 
in the countries with VHHDI, while more eﬀ ective 
preventive interventions are being developed. This target is 
a weighted average for 39 countries, and some countries 
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might achieve greater or smaller reductions. For example, 
our inter vention analysis shows that an 8% relative 
reduction in preterm birth rate is possible in the USA, but 
only 2% probable in Sweden (ﬁ gure 6B, C). Coincidentally, 
our USA result is remarkably consistent with the rate 
reduction target of 8% in the USA by 2014 put forth by the 
Association of State and Territorial Health Oﬃ  cials 
(ASTHO) and the March of Dimes, with pledges to date 
from 48 of the 50 states in the USA.
We have provided the analytical underpinning of the 
proposed 5% relative rate reduction target. Although 
previous targets have been set (eg, UNICEF Child 
Survival reduction of low birthweight goal set in 1990, US 
Healthy People 2020 preterm birth reduction goal, 
ASTHO), the quantitative basis for those goals are not in 
the public domain. While the setting of policy goals 
requires political traction, the transparent assessments 
of evidence and feasibility are crucial to consider as well, 
and we believe should be peer reviewed and published.
Half of the increased preterm birth rate in USA between 
1989 and 2004 is unexplained by this analysis, which is an 
important constraint in any analyses of preterm birth 
rates, and a widely-recognised, funda mental knowledge 
gap when observing increased spontaneous preterm birth 
and has implications for prevention. The ﬁ ndings from 
the USA might not be generalisable for other periods or 
to other countries, and we have not attempted to do so. 
Our analysis was constrained by the availability of 
likelihood ratios for preterm births that simultaneously 
adjusted for all other variables.8,34
When estimating the impact of existing interventions 
on preterm birth prevention we were able to include only 
ﬁ ve interventions. Other interventions may have an eﬀ ect 
but could not be included because of insuﬃ  cient data. 
Teenage pregnancy, for example, is relevant for economies 
of high, low, and middle income, but age-related preterm 
birth intervention data are missing. Other maternal 
chronic disorders such as hyper tensive disease of preg-
nancy, diabetes, and obesity associated with preterm birth 
are important contributors, but we were unable to 
estimate the eﬀ ect of interventions on their contributing 
factors because of insuﬃ  cient data regarding preterm-
speciﬁ c eﬀ ect.35–38 Interventions such as birth spacing and 
treatment of maternal infections (eg, syphilis, HIV/AIDS) 
are important interventions, especially in sub-Saharan 
Africa where preterm rates are highest, but again no or 
very few studies have assessed the eﬀ ect on preterm 
births.5,15 Newer studies suggest cervical pessary for 
women with short cervix might be a promising option 
awaiting more trials.39–42 These should all be areas of focus 
for future studies.
Importantly, although reduction of preterm birth 
focuses on stopping non-indicated preterm births, in 
some situations, such as eclampsia, preterm birth is 
deﬁ nitely indicated and is the only possible outcome for 
a live mother or baby or both. Thus, the goal of 0% 
preterm birth cannot be achieved unless preventive 
therapies are identiﬁ ed that eliminate all maternal, fetal, 
and obstetrical complications. Some of the increase in 
preterm birth is due to improved and totally appropriate 
obstetric management of poor fetal growth and the trade-
oﬀ  between stillbirth risk and yet minimising preterm 
birth risk is well recognised.43 These results provide 
estimates for the potential eﬀ ect of interventions, but do 
not oﬀ er guidance on individual clinical decision making. 
Additionally, despite their potential eﬀ ect in reduction of 
preterm births, interventions such as progesterone 
supplementation and cerclage might have potential risks 
associated with delayed labour that re quire further 
elucidation and must be tracked, such as later neuro-
psychological impairment.44
Our analysis of the preterm birth time trends and 
modelling of the baseline was constrained by the 
limited availability of trend data for preterm birth rates 
at national level. We had to rely on reported or Loess 
regression-ﬁ tted data.4 Although 60% (14 of 23 with 
suﬃ  cient time trend data) countries with VHHDI have 
a stable or decreasing preterm birth rate between 
2005 and 2010, the remaining 40% are still rising. If 
this trend were to reverse, and the preterm birth rates 
in countries with VHHDI rise again, then the estimated 
net change in preterm births from the 2010 baseline 
due to the preventive interventions would be even 
smaller. This is a real possibility given the absence of 
correlation between historical and future changes in 
preterm birth rates.
Panel: Research in context
Systematic review
An estimated 15 million babies are born too soon every year, with preterm birth the 
largest cause of neonatal death worldwide and second leading cause of deaths in children 
younger than 5 years. In the past two decades, preterm births have increased in all 
countries with reliable data. However, understanding of the drivers of preterm birth and 
the most eﬀ ective interventions to reduce preterm birth rates is poor. We used impact 
data from systematic reviews, assessing quality of evidence using GRADE, and coverage of 
interventions obtained from databases in the 39 countries including national health 
databases and statistical oﬃ  ces. Our analysis for 39 countries with VHHDI examines more 
recent trends, drivers of preterm birth rate increases in the USA, and estimates the eﬀ ect 
of interventions on preterm birth prevalence, including impact data from systematic 
reviews, and coverage of interventions obtained through database searches including 
national health databases and statistical oﬃ  ces.
Interpretation
To our knowledge, this is the ﬁ rst analysis to estimate the potential reduction in preterm 
births across high-income countries through preventive interventions. Our detailed 
analysis for the most recent decade suggests a levelling oﬀ  of the previous almost 
universal increasing rate in high-income countries. However, analysis of previous 
increases in one country (USA) show that about half of the increase cannot be accounted 
for. Our new analysis of the eﬀ ect of full coverage of fairly complex, available 
interventions, suggests that the scope for reducing preterm birth in these countries is 
estimated to be small (<5% relative reduction). This analysis highlights the need for the 
development of new and more eﬀ ective interventions for preterm births.
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Target population and coverage data also posed 
challenges. These interventions might overlap in their 
target population, resulting in an overestimation of their 
eﬀ ect. We tried to avoid this overestimation by carefully 
deﬁ ning the target population for every intervention. For 
example, eﬃ  cacy of cervical cerclage was estimated for 
women with previous preterm birth with short cervix, 
and that for progesterone was estimated for women with 
previous preterm birth but without short cervix.45
With respect to smoking cessation, only 25 of the 
39 included countries had data available of the percent 
of pregnant women smoking (appendix p 25) and we 
applied the mean from European countries. We assumed 
that the OR of preterm birth in mothers who smoked 
was biological in origin and could be modelled as a 
global-speciﬁ c rather than country-speciﬁ c risk.26 The 
reported eﬃ  cacy of smoking cessation programmes 
varies greatly depending on the study.22,28 We identiﬁ ed a 
single meta-analysis19 of eight randomised trials that 
directly reported the eﬃ  cacy of smoking ces sation 
programmes for pregnant women, which was used for 
all countries in the analysis and is an obvious 
simpliﬁ cation in view of probable diﬀ erences in eﬃ  cacy 
of such behavioural interventions across countries.19,46
For cervical cerclage, we deﬁ ned the target population 
as women with previous preterm birth and with short 
cervix, since data of the eﬃ  cacy of cervical cerclage were 
only available for this population.17 However, we were 
only able to identify published data about the present 
usage of cervical cerclage in all mothers, rather than our 
deﬁ ned target population for the USA.20 We therefore 
applied the assumption that the use of cervical cerclage 
was within our target population of women with short 
cervix and previous preterm birth, which is likely an 
overestimate, making our analysis conservative. No data 
of coverage of cervical cerclage were available for 
countries outside the USA; therefore this estimate was 
applied to all the included countries with VHHDI, which 
might diﬀ er substantially in obstetric practices.
We used the estimated potential eﬃ  cacy of proges-
terone from the recent systematic review.47 We assumed 
the target population for proges terone use to be only 
women with a singleton gestation with previous 
preterm birth without short cervix.45,48 This assumption 
was to avoid overlap of target population with that for 
cervical cerclage and thus indicates the incremental 
eﬀ ect in the population of progesterone on top of 
cervical cerclage. We were unable to identify national 
coverage data for progesterone use in countries with 
VHHDI. In view of this, we assumed that two-thirds of 
the indicated population has access to proges terone as 
the maximum possible existing coverage after consul-
tations with experts. This might be an overestimate and 
would surely vary by country. We expect the potential 
eﬀ ect of progesterone to be greater if true present 
coverage is lower than what we estimated, making our 
estimate conservative.
With respect to elective caesarean deliveries and 
induc tions without medical indication, the frequency of 
non-medically indicated labour induction and caesarean 
delivery is notoriously diﬃ  cult to estimate.49 We 
assumed that only late preterm births could potentially 
be non-medically indicated and that all moderate or 
early preterm births delivered through labour induc-
tion or caesarean deliveries were medically indicated. 
Analysis in Canada suggests that the issue is more 
through induction than caesarean delivery.50 We applied 
one published result for the USA from 2002–08, and 
scaled it to the rest of the world using reported country-
speciﬁ c elective caesarean delivery rates (appendix 
p 28).21,24 In view of the recent push to reduce incidence 
of late preterm births from labour induction or 
caesarean deliveries, this might be an overestimate. 
However, in the absence of other data, we chose to use 
this one result rather than make any new assumptions. 
Finally, for the purpose of this analysis, we assumed 
that 80% of the non-medically indicated labour 
induction and caesarean deliveries could be reduced in 
our target population. We recognise that this will vary 
from country to country.
For the analysis on decreasing multiple births from 
assisted reproductive technologies, the target plurality 
distribution for births with assisted reproductive tech-
nologies that we assumed is more stringent than many 
existing guidelines for assisted reproductive technologies29 
but for most European countries, the existing plurality 
distribution among assisted repro ductive technologies 
births is already at or better than our target rate, limiting 
the potential eﬀ ect of this intervention.10,18 In some 
countries, the target rate might be diﬃ  cult to achieve in 
view of current health-care reimbursement schemes for 
such technologies that may exclude ART; thus, patients 
must pay out of pocket and may be insistent on other 
than single embryo transfer. We also assumed that the 
rate of livebirths associated with assisted reproductive 
technologies would remain the same, which might diﬀ er 
from actual outcome.51
To estimate the total economic cost savings associated 
with reduction in preterm birth rate, we used the 
incremental cost associated with the care of an additional 
preterm birth from the USA Institute of Medicine (IOM) 
report32 and extrapolated to the rest of the countries with 
VHHDI, applying the purchasing power conversion in 
this extrapolation. The IOM report might substantially 
understate the cost of preterm birth. A high-quality 
study33 for England and Wales estimated the average cost 
of a preterm birth to be about $35 471. This cost is almost 
40% more than the roughly $25 688 we estimated for the 
UK using the US estimates from IOM and scaling based 
on purchasing power parity, suggesting that our 
$3 billion estimate of total cost might be substantially 
understated. We were unable to identify similar cost 
estimates for all countries with VHHDI, but recognise 
that there is a growing body of work on this topic, and a 
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more detailed country-by-country analysis would be 
valuable taking into account the gestational spectrum, 
which has been shown to substantially aﬀ ect costs.33
Although the present analysis focuses on the countries 
with VHHDI, applicability of these selected interven-
tions extends beyond these countries. For example, the 
prevalence of caesarean deliveries in some middle-
income countries is extremely high (eg, 46% for Brazil, 
38% for Mexico, and 26% for China); thus, the reduction 
of non-medically indicated caesarean deliveries could 
potentially have a large impact on reduction of preterm 
birth rate.21 Smoking in young women continues to 
rise in many emerging economies and cessation pro-
grammes might have a larger eﬀ ect in these societies. 
There are other preventive interventions, ranging from 
birth spacing to treating maternal infection, notably 
malaria, HIV, and syphillis, or improving nutrition, 
which are highly relevant for low-income and middle-
income countries. These were not included in our 
present analysis because they did not have suﬃ  ciently 
robust preterm-speciﬁ c impact data for in clusion and 
were less applicable to the countries with VHHDI.
By the year 2025, countries that take action now could 
potentially halve their deaths due to preterm births— 
a very large potential reduction on the mortality side, 
driven by current low coverage of care in low-income 
and middle-income countries.5 However, on the pre-
vention side, by 2015 at best we can reduce the preterm 
rates by only 5% in the richest countries if all countries 
can match the rate of relative reduction in preterm births 
among the top-performing countries and if these rather 
challenging existing interventions can be scaled up. 
Surely this humbling and shocking ﬁ nding must lead to 
strategic prioritisation of research into prevention of 
preterm births in countries with VHHDI. The path 
ahead includes improved appropriate classiﬁ  cation for 
the causes of preterm birth, allowing for better diagnosis 
and risk stratiﬁ cation, followed by develop ment of novel 
prevention interventions based on better understanding 
of the underlying aetiologic, intergen erational, and 
genetics studies.52–54 We hope that these new inter-
ventions, once developed, will also be rapidly translated 
from high-income countries to the rest of the world 
where the burden of preterm birth is even higher.
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